Gilead Waives Acquisition Option As Pionyr Explores Other Strategies

$315m Buy Off The Cards

Three blank, white signposts on a pink background, representing choice
Pionyr Can Now Consider Different Pathways For Its Future • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business